Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 3, 2014

Primary Completion Date

December 31, 2025

Conditions

Genetic Disorder

Trial Locations (1)

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

National Institutes of Health Clinical Center (CC)

NIH

collaborator

University of Massachusetts, Worcester

OTHER

lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT01851447 - Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy | Biotech Hunter | Biotech Hunter